Cargando…
DIAPH3 promotes pancreatic cancer progression by activating selenoprotein TrxR1‐mediated antioxidant effects
Pancreatic cancer is a highly malignant tumour of the digestive tract which is difficult to diagnose and treat. Approximately 90% of cases arise from ductal adenocarcinoma of the glandular epithelium. The morbidity and mortality of the disease have increased significantly in recent years. Its 5‐year...
Autores principales: | Rong, Yefei, Gao, Jie, Kuang, Tiantao, Chen, Jianlin, Li, Jian‐ang, Huang, Yufeng, Xin, Haiguang, Fang, Yuan, Han, Xu, Sun, Lun‐Quan, Deng, Yue‐Zhen, Li, Zhi, Lou, Wenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882936/ https://www.ncbi.nlm.nih.gov/pubmed/33345387 http://dx.doi.org/10.1111/jcmm.16196 |
Ejemplares similares
-
To inhibit TrxR1 is to inactivate STAT3–Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors
por: Busker, Sander, et al.
Publicado: (2020) -
A possible role for selenoprotein glutathione peroxidase (GPx1) and thioredoxin reductases (TrxR1) in thyroid cancer: our experience in thyroid surgery
por: Metere, Alessio, et al.
Publicado: (2018) -
Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma
por: Wang, Sicong, et al.
Publicado: (2023) -
TIGAR knockdown radiosensitizes TrxR1-overexpressing glioma in vitro and in vivo via inhibiting Trx1 nuclear transport
por: Zhang, Yushuo, et al.
Publicado: (2017) -
Activation of TAp73 and inhibition of TrxR by Verteporfin for improved cancer therapy in TP53 mutant pancreatic tumors
por: Acedo, Pilar, et al.
Publicado: (2019)